Sign In
Buy ISRG
$407.29
+4.99 (+1.24%)
At Close: Jun 03, 2026
ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures
01:10pm, Tuesday, 27'th Jan 2026
Intuitive Surgical wins FDA 510(k) clearance for the da Vinci 5 system in select cardiac procedures to expand minimally invasive heart surgery.
Forget Tech Stocks: The Medical Device Maker That's Essential to AI Healthcare
09:30am, Tuesday, 27'th Jan 2026
Intuitive Surgical's da Vinci surgical robots are in high demand. The high-growth company has begun incorporating AI into its technology.
CM WEALTH ADVISORS LLC Buys 1,454 Shares of Intuitive Surgical Inc (ISRG)
08:17am, Tuesday, 27'th Jan 2026
Summary CM WEALTH ADVISORS LLC initiated a new position in Intuitive Surgical Inc(ISRG), purchasing 1,454 shares valued at approximately $823,490 as of
Pre-Market Stock Futures: Futures are trading mixed after a solid start to the week, with all the major indices, except the Russell 2000, finishing the day higher. Anticipation of earnings reports fro
Generali Investments Towarzystwo Funduszy Inwestycyjnych Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG
05:02am, Tuesday, 27'th Jan 2026
Generali Investments Towarzystwo Funduszy Inwestycyjnych raised its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 52.6% in the third quarter, according to the company in its most re
China Remains Competitive: Can ISRG Defend Share Amid Local Rivals?
10:51am, Monday, 26'th Jan 2026
ISRG faces slower China tenders, local favoritism and pricing pressure, even as clinicians prefer da Vinci and management flags 2026 competition.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
10:11am, Monday, 26'th Jan 2026
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Da Vinci 5 Cleared for Cardiac Procedures
09:15am, Monday, 26'th Jan 2026
SUNNYVALE, Calif. , Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors
11:44am, Sunday, 25'th Jan 2026
Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech, leavi
Cullen Frost Bankers Inc. Buys 3,450 Shares of Intuitive Surgical, Inc. $ISRG
06:02am, Sunday, 25'th Jan 2026
Cullen Frost Bankers Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 4.4% during the third quarter, according to the company in its most recent disclosure with the Securities and
Benzinga Bulls And Bears: Netflix, Capital One, Intuitive Surgical — And Markets Ride Greenland Roller Coaster
08:01am, Saturday, 24'th Jan 2026
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories.
3 Troubling Trends for Intuitive Surgical – and 1 Bright Spot
03:45am, Saturday, 24'th Jan 2026
Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026.
Intuitive Surgical Q4 Earnings Call Highlights
03:04am, Saturday, 24'th Jan 2026
Intuitive Surgical (NASDAQ: ISRG) outlined what executives called a "strong year" in 2025, driven by multi-specialty procedure growth, increasing adoption of the da Vinci 5 platform, and continued exp
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
06:30pm, Friday, 23'rd Jan 2026
Bristol Myers Squibb just announced an important partnership with Microsoft that involves AI. Intuitive Surgical has integrated AI real-time processing into its surgical robots, but that could be just
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
12:45pm, Friday, 23'rd Jan 2026
Intuitive Surgical stock gains after Q4 EPS and revenue top estimates as system placements and procedure growth offset a decline in gross margin.
